167 related articles for article (PubMed ID: 17921723)
1. Cancer stem cells: implications for cancer treatment and prevention.
Kakarala M; Wicha MS
Cancer J; 2007; 13(5):271-5. PubMed ID: 17921723
[No Abstract] [Full Text] [Related]
2. [Stem cell-targeted therapy--a new strategy for cancer treatment].
Chen G; Xie L; Liu BR
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):801-3. PubMed ID: 19173821
[No Abstract] [Full Text] [Related]
3. ABCG2: the key to chemoresistance in cancer stem cells?
An Y; Ongkeko WM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
[TBL] [Abstract][Full Text] [Related]
4. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Cojoc M; Mäbert K; Muders MH; Dubrovska A
Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
[TBL] [Abstract][Full Text] [Related]
5. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.
Donnenberg VS; Donnenberg AD
J Clin Pharmacol; 2005 Aug; 45(8):872-7. PubMed ID: 16027397
[TBL] [Abstract][Full Text] [Related]
6. [An update: stem cell and cancer stem cells].
Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
[No Abstract] [Full Text] [Related]
7. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.
Moitra K; Lou H; Dean M
Clin Pharmacol Ther; 2011 Apr; 89(4):491-502. PubMed ID: 21368752
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells in the crosshairs.
Schmidt C
Cancer Discov; 2012 May; 2(5):384. PubMed ID: 22588862
[No Abstract] [Full Text] [Related]
9. The cancer stem-cell signaling network and resistance to therapy.
Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis.
Savage P
BMC Cancer; 2016 Nov; 16(1):906. PubMed ID: 27871274
[TBL] [Abstract][Full Text] [Related]
11. Tumour stem cells and drug resistance.
Dean M; Fojo T; Bates S
Nat Rev Cancer; 2005 Apr; 5(4):275-84. PubMed ID: 15803154
[TBL] [Abstract][Full Text] [Related]
12. The cancer stem cell gamble.
Kaiser J
Science; 2015 Jan; 347(6219):226-9. PubMed ID: 25593170
[No Abstract] [Full Text] [Related]
13. The ABCs of cancer stem cell drug resistance.
Elliott A; Adams J; Al-Hajj M
IDrugs; 2010 Sep; 13(9):632-5. PubMed ID: 20799146
[TBL] [Abstract][Full Text] [Related]
14. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
McIntosh K; Balch C; Tiwari AK
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Therapeutic Implications of Cancer Stem Cells.
Clarke MF
N Engl J Med; 2019 Jun; 380(23):2237-2245. PubMed ID: 31167052
[No Abstract] [Full Text] [Related]
16. Cancer stem cell epigenetics and chemoresistance.
Crea F; Danesi R; Farrar WL
Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z; Gabrisova V; Kucerova L
Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
[TBL] [Abstract][Full Text] [Related]
18. Glioma stem cells: their role in chemoresistance.
Yamada R; Nakano I
World Neurosurg; 2012 Feb; 77(2):237-40. PubMed ID: 22501017
[No Abstract] [Full Text] [Related]
19. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
Topcul M; Cetin I
J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell targeted therapy: progress amid controversies.
Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
